SELLAS Life Sciences (SLS) Enterprise Value (2019 - 2024)
SELLAS Life Sciences (SLS) has disclosed Enterprise Value for 9 consecutive years, with -$100000.0 as the latest value for Q3 2024.
- On a quarterly basis, Enterprise Value rose 97.5% to -$100000.0 in Q3 2024 year-over-year; TTM through Sep 2024 was -$100000.0, a 97.5% increase, with the full-year FY2023 number at -$100000.0, changed 0.0% from a year prior.
- Enterprise Value was -$100000.0 for Q3 2024 at SELLAS Life Sciences, roughly flat from -$100000.0 in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$100000.0 in Q1 2020 to a low of -$35.3 million in Q4 2020.
- A 5-year average of -$6.4 million and a median of -$100000.0 in 2020 define the central range for Enterprise Value.
- Peak YoY movement for Enterprise Value: crashed 35202.0% in 2020, then skyrocketed 99.72% in 2021.
- SELLAS Life Sciences' Enterprise Value stood at -$35.3 million in 2020, then soared by 99.72% to -$100000.0 in 2021, then changed by 0.0% to -$100000.0 in 2022, then changed by 0.0% to -$100000.0 in 2023, then changed by 0.0% to -$100000.0 in 2024.
- Per Business Quant, the three most recent readings for SLS's Enterprise Value are -$100000.0 (Q3 2024), -$100000.0 (Q2 2024), and -$18.4 million (Q1 2024).